Clinical Trials Browser

Recruiting × Graft vs Host Disease × Mycophenolic Acid × Clear all

NCT07359859 2026-05-27

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

Phase 2 Recruiting

40 enrolled

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

NCT07566377 2026-05-14

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Phase 2 Recruiting

71 enrolled

LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06996119 2026-05-11

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

Phase 1 Recruiting

15 enrolled

MyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06926595 2026-04-03

GVHD-PTCy

Phase 2 Recruiting

41 enrolled

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

NCT06799195 2025-12-15

PTCYGVHD

Phase 2 Recruiting

126 enrolled

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms